Jump to content

Lung cancer drug on fast-track to FDA approval

Recommended Posts

KUSA - A lung cancer drug produced by Boulder-based company is on the fast-track for FDA approval.

Monday afternoon the FDA announced it granted Clovis Oncology 'breakthrough therapy' status for one of its treatments. The drug, known as CO-1686, treats Stage 4 lung cancer. It's been effective in clinical trials on patients for which other therapies have not worked or produced severe side effects.

The 'breakthrough therapy' designation stems from a provision written by Sen. Michael Bennet (D), which passed congress in 2012. It puts some life-saving drugs on pace to get faster approval from the FDA, while maintaining safety, if they show dramatic results in early clinical trials.

"Today we see a great example in Colorado of a company that's seizing the future. That's growing. That's paying good wages. And that's saving people along the way," Bennet said.

Bennet says since the bill passed more than 40 drugs, treating everything from Hepatitis C to cystic fibrosis, have been put on the fast track to FDA approval.

(KUSA-TV © 2014 Multimedia Holdings Corporation)

http://www.9news.com/story/news/local/2 ... l/9313169/

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use.